F5, Inc. (NASDAQ:FFIV – Get Free Report) insider John Maddison sold 204 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $406.24, for a total value of $82,872.96. Following the transaction, the insider owned 1,149 shares in the company, valued at $466,769.76. This trade represents a 15.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John Anthony Maddison also recently made the following trade(s):
- On Monday, August 3rd, John Maddison sold 1,000 shares of F5 stock. The stock was sold at an average price of $405.85, for a total transaction of $405,850.00.
F5 Stock Up 4.7%
FFIV stock traded up $19.39 during trading on Tuesday, hitting $430.88. 638,391 shares of the company’s stock traded hands, compared to its average volume of 732,461. The stock has a market capitalization of $24.40 billion, a price-to-earnings ratio of 34.31, a price-to-earnings-growth ratio of 4.02 and a beta of 1.03. F5, Inc. has a 52 week low of $223.76 and a 52 week high of $435.00. The stock has a fifty day moving average price of $403.34 and a two-hundred day moving average price of $362.06.
Analyst Ratings Changes
A number of brokerages have issued reports on FFIV. Morgan Stanley raised their target price on shares of F5 from $380.00 to $415.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of F5 in a report on Tuesday, July 28th. Wall Street Zen upgraded F5 from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Royal Bank Of Canada reissued an “outperform” rating on shares of F5 in a report on Thursday, July 16th. Finally, Piper Sandler restated an “overweight” rating and set a $461.00 price objective (up from $423.00) on shares of F5 in a research report on Tuesday, July 28th. Five investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $416.62.
Check Out Our Latest Stock Report on FFIV
Institutional Trading of F5
Large investors have recently modified their holdings of the company. Persistent Asset Partners Ltd acquired a new position in F5 during the 2nd quarter valued at about $36,000. Hazlett Burt & Watson Inc. acquired a new stake in shares of F5 in the fourth quarter valued at approximately $26,000. Hantz Financial Services Inc. increased its stake in shares of F5 by 109.8% in the fourth quarter. Hantz Financial Services Inc. now owns 107 shares of the network technology company’s stock valued at $27,000 after purchasing an additional 56 shares during the period. Elyxium Wealth LLC acquired a new stake in shares of F5 in the fourth quarter valued at approximately $28,000. Finally, SJS Investment Consulting Inc. raised its holdings in shares of F5 by 963.6% during the first quarter. SJS Investment Consulting Inc. now owns 117 shares of the network technology company’s stock valued at $34,000 after buying an additional 106 shares during the last quarter. Institutional investors and hedge funds own 90.66% of the company’s stock.
F5 Company Profile
F5, Inc is a technology company that provides application delivery, security and traffic-management solutions for enterprises, service providers and government organizations. Its offerings are designed to help customers ensure the availability, performance and security of applications across on-premises data centers, public clouds and edge environments.
The company’s portfolio includes BIG-IP software and appliances, NGINX application delivery and web server technologies, and F5 Distributed Cloud Services.
Recommended Stories
- Five stocks we like better than F5
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for F5 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for F5 and related companies with MarketBeat.com's FREE daily email newsletter.
